Home/Products/Wegovy 1.7mg FlexTouch/

Wegovy 1.7mg FlexTouch 3.0 ml in 1 pre-filled pen

Last Updated:

Wegovy 1.7mg FlexTouch is a product of Novo Nordisk India Pvt Ltd

Composition: Semaglutide (1.7mg)

Pack of 3 ml

₹ 16400.00

Note: MRP can vary depending up on batch!

*MRP inclusive of all taxes
Related Products

    All Details About Wegovy 1.7mg FlexTouch

    Find out detailed description, uses, directions of use, side effects, warnings and precautions, frequently asked questions about Wegovy 1.7mg FlexTouch

    Description:

    Wegovy 1.7mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

    Wegovy 1.7mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.


    The most common side effects of Wegovy 1.7mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.


    Earlier starting Wegovy 1.7mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Increaseitionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1.7mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

    Uses:

    Directions For Use:

    Wegovy 1.7mg FlexTouch comes in a prefilled pen designed for self-administration and is convenient to use. However, speak with your doctor or healthcare provider for proper training, either for you or your caregiver, to ensure safe and effective use at home.

    Side Effects:

    Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

    Ordinary side effects of Wegovy

    • Nausea
    • Vomiting
    • Diarrhea
    • Constipation
    • Stomach pain

    Warning & Precautions:

    Alcohol
    CONSULT YOUR DOCTOR
    It is not known whether it is safe to consume alcohol with Wegovy 1.7mg FlexTouch. Please consult your doctor.
    Pregnancy
    CONSULT YOUR DOCTOR
    The safety of Wegovy 1.7mg FlexTouch during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
    Breast feeding
    CAUTION
    Wegovy 1.7mg FlexTouch should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
    Driving
    SAFE
    Wegovy 1.7mg FlexTouch does not usually affect your ability to drive.
    However, some people may experience dizziness during dose escalation. Do not drive if you experience dizziness.
    Kidney
    SAFE IF PRESCRIBED
    Wegovy 1.7mg FlexTouch is safe to use in patients with kidney disease. No dose adjustment is recommended.
    Liver
    SAFE IF PRESCRIBED
    Wegovy 1.7mg FlexTouch is safe to use in patients with liver disease. No dose adjustment is recommended.

    FAQs:

    What is Wegovy 1.7mg FlexTouch, and what is it used for?

    Wegovy 1.7mg FlexTouch is a prescription medicine used for weight loss and weight maintenance in people (18 years and above) who are obese or overweight. It helps reduce the risk of serious heart problems like heart attack or stroke in people with type 2 diabetes and established heart disease.

    How often do I need to take Wegovy 1.7mg FlexTouch?

    Wegovy 1.7mg FlexTouch is administered once a week as an injection under the skin. Your doctor will guide you on how to use it properly and where to inject it.

    Does Wegovy 1.7mg FlexTouch cause low blood sugar (hypoglycemia)?

    While Wegovy 1.7mg FlexTouch alone is unlikely to cause low blood sugar, the risk may increase if it is used alongside other diabetes medicines, such as insulin or sulfonylureas. To minimize this risk, monitor your blood sugar levels regularly and follow your doctor’s guidance on dosing.

    Are there any serious risks associated with Wegovy 1.7mg FlexTouch?

    In rare cases, Wegovy 1.7mg FlexTouch can increase the risk of pancreatitis, thyroid tumors, or low blood sugar (especially if taken with other diabetes medications). Let your doctor know if you have a personal or family history of thyroid cancer or severe stomach issues.

    How should I store Wegovy 1.7mg FlexTouch?

    Store Wegovy 1.7mg FlexTouch in the refrigerator until you are ready to use them. Do not freeze the medicine, and protect them from direct sunlight.

    Are Wegovy 1.7mg FlexTouch and Ozempic exactly the same?

    Wegovy 1.7mg FlexTouch and Ozempic are different brand names for the same medication, semaglutide. However, they are approved for different purposes and dosed differently. One of the most important differences is that Wegovy 1.7mg FlexTouch is prescribed to manage weight in adults 18 and above who are overweight or obese (approved age range in India). Ozempic is advised to lower blood sugar when you have type 2 diabetes. Please note that only Wegovy is approved in India by the CDSCO (Central Drugs Standard Control Organisation) as of now.

    Written by:
    Dr. T. Sharmila Krishna
    M.B.B.S., MD (Biochemistry)

    Reviewed by:
    Dr. Sureshbabu Yadav
    M.B.B.S., DIP.DIAB, F.R.S.H

    Disclaimer:

    Getomeds primary intention is to ensure that its consumers get information that is reviewed by experts, accurate, and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all of your concerns about any disease or medication. Do not disregard or postpone seeking professional medical advice because of something you read on Getomeds. Our mission is to support, not replace, the doctor-patient relationship.